GSK Receives Positive Opinion For Alli(R) (orlistat 60 Mg) As A Non-prescription Weight Loss Aid In Europe
Thursday 23 October 2008, London GlaxoSmithKline (GSK) announced today that alli (orlistat 60 mg) has received a positive opinion as a non-prescription product from the Committee for Medicinal Products for Human Use (CHMP). This means the product will now be proposed for final approval by the European Commission and marketing authorisation could be granted in the coming months.
More: continued here
Filed under: Obesity / Weight Loss / Fitness on October 27th, 2008